Masuda, T., Fukuda, A., Yamakawa, G., Omatsu, M., Namikawa, M., Sono, M., . . . Seno, H. (2023). Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis. The Journal of clinical investigation, 133(18), 1-14. https://doi.org/10.1172/JCI161847
Chicago Style (17th ed.) CitationMasuda, Tomonori, et al. "Pancreatic RECK Inactivation Promotes Cancer Formation, Epithelial-mesenchymal Transition, and Metastasis." The Journal of Clinical Investigation 133, no. 18 (2023): 1-14. https://doi.org/10.1172/JCI161847.
MLA (9th ed.) CitationMasuda, Tomonori, et al. "Pancreatic RECK Inactivation Promotes Cancer Formation, Epithelial-mesenchymal Transition, and Metastasis." The Journal of Clinical Investigation, vol. 133, no. 18, 2023, pp. 1-14, https://doi.org/10.1172/JCI161847.